Oliman, Nelfa .
HRN: 14-01-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/18/2024
05/24/2024
IV
500mg
Q8
Intestinal Amoebiasis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes